Delivery Order SPE2DB20D1100-SPE2DB25FY98C

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,542.09 firm fixed-price delivery order has a completion date of September 12, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,168.29 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025 with a completion date of February 19, 2025. The contract is a Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
The federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $18,893.70, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 6, 2025. The contract is not set-aside and allows for open...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract, valued at $19,360.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,423.32 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 23, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of ONDANSETRON ODT 8 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract, valued at $1,840.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 4, 2024, with a completion date of September 5, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. This contract is...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The $1,041.90 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 1, 2023. The contract has a period of performance through March 2, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $2,019.63. The contract is a delivery order and has a firm fixed price pricing type. The contract does not have a set-aside designation and has an ultimate completion date of August 16, 2024. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $4,000.89, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on August 28, 2024, with a completion date of August 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a...
This federal contract award is for the supply of 4560762424 - ONDANSETRON ODT 8 MG TABLET 30S to the Defense Logistics Agency (DLA). The $30,916.61 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 28, 2023. The contract has a period of performance through May 1, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FY98C
    Delivery Order

This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,125.04 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024, with a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 5/20/25, 1:55 PM